Cogstate Limited (CGS.AX)
Creates digital tests that measure brain health and cognitive decline for drug trials and patient care.
2.60+0.06%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+49.9%
The outlook
Cogstate is trading near the middle-to-upper portion of its 52-week range, with analyst sentiment leaning bullish overall. The average analyst price target sits roughly 36% above the current price, though the stock's movement relative to its short-term moving averages appears mixed. At a trailing P/E of 28.9, valuation reflects growth expectations.
What’s behind the score
Price trendMixed vs its moving averages
52-week range72% of the way from its 52-week low to high
Price targetAvg target +36% vs current price
Analyst price target
~12-month · 2 analysts3.54average target+36.2% vs now
Now 2.60
Low 3.38High 3.70
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$441.8M
52-wk high
3.01
52-wk low
1.55
50-day avg
2.68
200-day avg
2.43
Trailing P/E
28.9